387 related articles for article (PubMed ID: 11896065)
21. Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features.
Fraga M; Forteza J
Histol Histopathol; 2007 Aug; 22(8):923-35. PubMed ID: 17503349
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
23. Classification of Hodgkin's disease biopsies by a panel of four histopathologists. Report of 1,140 patients from the German National Trial.
Georgii A; Fischer R; Hübner K; Schwarze EW; Bernhards J
Leuk Lymphoma; 1993 Mar; 9(4-5):365-70. PubMed ID: 8348072
[TBL] [Abstract][Full Text] [Related]
24. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
27. Epstein Barr virus latent membrane protein-1 in Hodgkin's lymphoma in Nigerians.
Adelusola KA; Titiloye NA; Rotimi O; Durosinmi M
Afr Health Sci; 2009 Sep; 9(3):174-8. PubMed ID: 20589147
[TBL] [Abstract][Full Text] [Related]
28. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
Carbonnelle A; Delarue R; Canioni D; Brousse N
Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
[TBL] [Abstract][Full Text] [Related]
30. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
31. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
32. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
33. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
34. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
35. [Hodgkin disease: recent histological and biological data].
Charlotte F
Rev Med Interne; 1995; 16(5):336-43. PubMed ID: 7597319
[TBL] [Abstract][Full Text] [Related]
36. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
[TBL] [Abstract][Full Text] [Related]
37. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
38. Coexistence of nodular lymphocyte predominance Hodgkin's disease and Hodgkin's disease of the usual type.
Gelb AB; Dorfman RF; Warnke RA
Am J Surg Pathol; 1993 Apr; 17(4):364-74. PubMed ID: 8494105
[TBL] [Abstract][Full Text] [Related]
39. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
40. Hodgkin lymphoma: an update on its biology with new insights into classification.
Mani H; Jaffe ES
Clin Lymphoma Myeloma; 2009 Jun; 9(3):206-16. PubMed ID: 19525189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
